GALMED PHARMACEUTICALS LTD. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-12-31 | $61.00K 20-F · filed 2023-03-29 | |
| 2017-12-31 | $530.00K 20-F · filed 2019-03-13 | |
| 2016-12-31 | $255.00K 20-F · filed 2018-03-13 |